Dr. Tolbert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 Gillham Rd
Kansas City, MO 64108Phone+1 816-234-3000Fax+1 816-302-9894- Is this information wrong?
Education & Training
Children’s Mercy HospitalFellowship, Pediatric Hematology/Oncology, 2012 - 2015
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2009 - 2012
LSU School of Medicine in ShreveportClass of 2009- Xavier University of LouisianaBS, Biology/Chemistry, 1998 - 2002
Certifications & Licensure
MO State Medical License 2012 - 2020
KS State Medical License 2015 - 2019
Publications & Presentations
PubMed
- 15 citationsIncreasing Resident Racial and Ethnic Diversity through Targeted Recruitment Efforts.Tamorah R Lewis Md PhD, Jaszianne A. Tolbert, Bridgette L. Jones
The Journal of Pediatrics. 2020-01-01 - 4 citationsClinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.Ajai Chari, Amrita Krishnan, Leo Rasche, Jing Christine Ye, Alfred Garfall
Clinical Lymphoma, Myeloma & Leukemia. 2024-10-01 - 2 citationsCusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose opti...Thomas Pabst, Cristina Papayannidis, Fatih Demirkan, Vadim Doronin, Laura M Fogliatto
The Lancet. Haematology. 2023-11-01
Journal Articles
- The Creating Hope Act: What Is Old Is New AgainTolbert J, Goldman J, Kaufmann R, Abdel-Rahman S, Pediatric Health, Medicine and Therapeutics, 1/1/2014
- Common Acquired Causes of Thrombosis in ChildrenTolbert J, Carpenter S, Current Problems in Pediatric and Adolescent Health Care, 1/1/2013
Abstracts/Posters
- Pharmacokinetics (PK) of Two 6-Mercaptopurine (6-MP) Liquid Formulations in Children with Acute Lymphoblastic Leukemia (ALL).Tolbert JA, Kearns GL, Abdel-Rahman SM, Weir SJ, Leeder JS, Neville KA, Clinical Pharmacology and Therapeutics, Annual Meeting of the American Society of Clinical Pharmacology and Therapeutics (ASCPT), New Orleans, LA, 1/1/2015
- Gemtuzumab Ozogamicin (GO) And Toxic Mortality (TM) In Children and Adolescents with Acute Myeloid Leukemia (AML) Enrolled on Children's Oncology Group (COG) Trial AAM...Tolbert J, Sung L, Aplenc R, Alonzo T, Wang Y, Gerbing R, Mesinchi S, Gamis A, Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2015
- Pharmacokinetics and Relative Oral Bioequivalence of Two 6-Mercaptopurine (6-MP) Liquid Formulations in Children with Acute Lymphoblastic Leukemia (ALL).Tolbert JA, August, KJ, Abdel-Rahman SM, Weir SJ, Leeder JS, Neville KA, CMH Annual Research Days, Children's Mercy Hospital, Kansas City, MO, 1/1/2015
- Join now to see all
Lectures
- The Challenge of Obesity in Pediatric Leukemia TreatmentChildren's Mercy Hospital, Kansas City, MO - 1/1/2015
- Hepatoblastoma: Case report and Current Diagnostic and Surgical GuidelinesKansas City, MO - 1/1/2015
- Rhabdomyosarcoma: Current Diagnostic and Treatment GuidelinesKansas City, MO - 1/1/2015
- Join now to see all
Press Mentions
Web Extra: Inside 'Inside Pediatrics'February 11th, 2019
Improving Pediatric Hematology Oncology Outcomes Through Precision Medicine and Experimental TherapeuticsFebruary 6th, 2019
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
